Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK.
Jozaa Z ALTamimiGhedier M Al-ShammariNora Abdullah AlFarisReham I AlagalDalal H AljabrynNorah A AlbekairiMahmoud Ahmad AlkhateebMohammed Abdo YahyaPublished in: Pharmaceutical biology (2022)
studies are needed to validate its potential in clinical medicine.